The use of delamanid in the treatment of multidrug-resistant tuberculosis: interim policy guidance
The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...
Análise Custo-Benefício, Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico, Quimioterapia Combinada, Nitroimidazóis/uso terapêutico, Resultado do Tratamento, Antituberculosos/uso terapêutico, Tuberculose Pulmonar/tratamento farmacológico, Ensaios Clínicos como Assunto, Nitroimidazóis/economia, Antituberculosos/economia